Medtronic has raised its fiscal year 2026 (FY26) profit outlook to between $5.62 and $5.66 per share after the company achieved its strongest cardiovascular portfolio revenue growth in over a decade ...

Freenome has announced a strategic agreement with Roche aimed at commercialising its cancer screening technology outside the ...

Distalmotion has closed a Series G funding round totalling $150m to expedite the expansion of its soft tissue robotic surgery ...